A higher focus on market access strategies, managed markets and salesforce realignments are the elements of addressing that pain
The changes in the pharma market—with physicians declining as the primary marketing target, and centralized healthcare management (whether by healthcare providers themselves or by governments) rising—is an established trend that the industry is moving through. But now the consequences of this transformation are deepening, according to the just-released 2011 Pharma Insights report from Cegedim Relationship Management (Bedminster, NJ). “Changing commercial models” is now the top concern of executives (at US companies) polled, outranking the traditional worry over pipeline development for new products. And while physicians are still the primary customer group—with 42% of respondents signifying them—patients, government and managed care organizations now cover the rest.
The main priorities for executing new commercial models are “increased focus on market access strategies,” “increased focus on managed markets,” and “primary sales force realignment.” To address today’s market, strategic business planning has declined as the primary driver of change; now that responsibility is being more or less shared by it, commercial operations and sales/marketing. Cegedim, which offers both sales force automation tools and consulting and compliance services, chose social media and tablet/iPad usage as two of the components of how marketing and sales are being managed; the respondents indicate that LinkedIn is outgunning Facebook as a social medium, and that while 35% say they are already using tablets in their organization, 21% will be adding them in the next year.
“Survey respondents highlight the need for more specialized and intuitive strategies and technology-based solutions, and in a comparison to last year’s findings, it is an increasing and continued trend shaping the way companies prepare for the future," said Angela Miccoli, president, North America, Cegedim Relationship Management. “Our role in the industry is to respond to these trends and challenges by continuing to provide innovative technology solutions.” The full survey is available from Cegedim.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.